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Abstract: National HIV incidence for a given year x [I(x)] equals prevalence [P(x)] times the transmission rate [T(x)]. Or, 
simply rearranging the terms, T(x) = [I(x)/P(x)]*100 (where T(x) is the number of HIV transmissions per 100 persons 
living with HIV in a given year). The transmission rate is an underutilized measure of the speed at which the epidemic is 
spreading. Here, we utilize recently updated information about HIV incidence and prevalence in the U.S. to estimate the 
national HIV transmission rate for 2006 through 2008, and present a novel method to express the level of uncertainty in 
these estimates. Transmission rate estimates for 2006 through 2008 are as follows (respectively): 4.39 (4.01 to 4.73); 4.90 
(4.49 to 5.28); and 4.06 (3.70 to 4.38). Although there are methodological challenges inherent in making these estimates, 
they do give some indications that the U.S. HIV transmission rate is at a historically low level. 
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INTRODUCTION 
  Fundamentally, at a national level, HIV incidence for a 
given year x [I(x)] equals prevalence [P(x)] times the 
transmission rate [T(x)]. Or, simply rearranging the terms, 
T(x) = [I(x)/P(x)]*100 (where T(x) is easily interpreted as 
the number of HIV transmissions per 100 persons living with 
HIV in a given year) [1-6]. 
  Despite the central role that T(x) plays in the 
epidemiology of HIV, there has been relatively scant 
attention paid in the literature to its calculation [1-6]. We 
previously estimated the HIV transmission rate for the U.S. 
for 1977 through 2006 based on extended backcalculation 
estimates for I(x) and P(x) [6].
  For the year 2006, we 
estimated that T(x) was 5.0 in the U.S. (i.e., that there were 
approximately 5.0 HIV transmissions to HIV seronegative 
persons for every 100 persons living with HIV in that year) 
[6]. However, the attention being given to the HIV 
transmission rate is increasing since last year's release of the 
National HIV/AIDS Strategy which set major national goals 
of reducing HIV incidence by 25% and reducing T(x) by 
30% between 2010 and 2015 [7]. 
 Very  recently,  CDC  updated its estimates of I(x) and P(x) 
for 2006, and added new estimates for 2007 and 2008 [8, 9]. 
P(x) estimates for 2006 through 2008 are still based on 
extended backcalculation methodology [9]. I(x) estimates for 
these three years, however, are based on a stratified 
extrapolation approach (SEA) for HIV incidence estimation 
based on a biological marker of recent HIV infection, the 
BED HIV-1 Capture EIA (BED), that classifies a diagnosed  
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HIV infection as either of recent (on average within 162 
days) [10] or long-standing duration. Incidence is estimated 
using the SEA by assigning a weight (based on the 
probability that an individual of similar demographic and 
risk behavior characteristics would have an HIV test in 
his/her recency period) to each diagnosis deemed a recent 
infection, and summing these weights [8, 11]. By using the 
SEA, annual HIV incidence estimates can be calculated to 
provide the most up to date information on the burden of 
HIV infection. I(x) and P(x) base case, lower bound and 
upper bound estimates published by CDC are presented in 
Table 1. 
  To calculate T(2006), T(2007) and T(2008) we must use 
a BED-based estimate for the numerator and an extended 
backcalculation estimate for the denominator as there are no 
published I(x) and P(x) pairs based on the same 
methodology for these three years. This reflects CDC's 
position that these methods are the best available to estimate 
incidence, and prevalence respectively. It is instructive to 
make these calculations to gauge the approximate 
transmission rate for the U.S. based on the best available 
incidence and prevalence estimates in the U.S. even though 
there are methodological differences. Table 1 displays the 
results of these calculations. We had previously estimated 
T(2006) to be 5.0; the updated estimate for T(2006) is 4.39 
(Table  1); this difference is simply the result of using 
different methodologies to estimate I(x). T(2007) and 
T(2008) estimates are 4.90 and 4.06, respectively. Such 
estimates would indicate that over 95% of persons living 
with HIV do not transmit the virus to a seronegative person 
in a given year (and that percentage is even higher to the 
extent that there is clustering of HIV transmission; ie, one 
person infecting more than one person). 
  Of course, there is clearly uncertainty in these estimates 
of T(x). One way to explore this uncertainty is to consider 
the 95% confidence intervals around I(x) and P(x). The HIV Transmission Rates in the United States, 2006-2008  The Open AIDS Journal, 2012, Volume 6    27 
original confidence intervals for I(x) and P(x) are provided 
in Table 1, and the reader is referred to the original sources 
for a complete discussion of their derivation [8, 9]. For 
instance, one might estimate a lower bound for T(x) by 
dividing the lower bound estimate of I(x) by the lower bound 
estimate of P(x), and an upper bound estimate for T(x) by 
dividing the upper bound estimate of I(x) by the upper bound 
estimate of P(x). The results of these calculations are 
displayed in Table 1, and would indicate lower and upper 
bounds of less than 9% variance from the base case estimates 
of T(x). 
  Although a variance of less than 9% from base case is a 
rather narrow range, there is some evidence that even this 
range is possibly too wide. This evidence comes from 
comparing CDC's previous estimates of deaths among 
persons living with HIV (given in the footnote of Table 1) 
[12] to the number of deaths implied by I(x), P(x) and P(x-1) 
(calculated in Table 1). That is, if we take published 
estimates of P(x) and I(x) [8, 9], we can calculate the number 
of implied deaths by using the formula, 
Implied Deaths (x) = P(x) - [P(x-1) + I(x)]. 
  In the base case calculations for T(2007) and T(2008) we 
see that the number of implied deaths are 20,000 and 11,850, 
respectively (with a two year average of 15,925). Given 
CDC's previously published estimates of deaths among 
persons living with HIV in 40 states (16,297 for 2007, 
16,769 for 2008, and a two year average of 16,533) [12], the 
implied deaths are a bit too low for 2008 and the two year 
average. The latest data available on deaths are from the 40 
states that have had confidential, name-based HIV infection 
reporting for a sufficient length of time to adjust for 
reporting delays. 
  Examining the lower bound calculations from Table 1 we 
see that the implied deaths are substantially too low. For 
2008, the implied deaths may also be too low in the higher 
bound calculations given that CDC's published death 
estimates are for 40 states only. These observations about 
observed and implied numbers of deaths might suggest that 
the T(x) bounds calculated in Table 1 are somewhat too wide 
(however, this assertion is not definitive because the driver 
of the implied deaths discrepancy from previously estimated 
deaths could be a function of uncertainty in I(x), P(x) or 
some combination of the two). We include this tentative 
discussion of implied deaths simply to highlight that the 
amount of uncertainty implied in Table 1 about T(x) may 
well be too high rather than too low. 
  It is important to note that we did not attempt to calculate 
the HIV transmission rate for specific subpopulations such as 
African-American communities and men who have sex with 
men. To do so would be to imply that all incidence occurs 
within particular communities and there is no sexual or 
injection equipment sharing across subpopulations; clearly 
this is a problematic assumption to make. 
  Of much policy and programmatic interest is whether 
there is a discernable upward or downward trend in the 
transmission rate from year to year. The T(2006-2008) 
estimates calculated in this report do not indicate an obvious 
trend in either direction, although further years of data are 
needed. This result might indicate relatively overall stability 
in the T(x) for these three years. If stability is a reasonable 
description of T(x) for this time period, then taking the 
arithmetic average of T(x) for 2006-2008 would be an 
appropriate calculation. The unweighted average of T(2006), 
T(2007) and T(2008) is 4.45 in the base case, 4.07 in the 
"lower bound" case, and 4.80 in the "upper bound" case. 
Table 1.  Annual HIV Transmission Rates per 100 Persons Living with HIV [T(x)], 2006-2008 
 
HIV   Lower   Upper  HIV  Lower  Upper  Deaths  HIV 
Incidence  Bound  Bound  Prevalence  Bound  Bound  Implied By I(x),  Transmission Rate  Year (x) 
I(x)  I(x)  I(x)  P(x)  P(x)  P(x)  P(x), & P(x-1)*  T(x)=[I(x)/P(x)]*100 
Base Case 
2006  48,600 NA  NA  1,106,400 NA  NA  NA  4.39
2007  56,000 NA  NA  1,142,400 NA  NA  20,000 4.90
2008  47,800 NA  NA  1,178,350 NA  NA  11,850 4.06
"Lower Bound" 
2006  NA  42,400 NA  NA  1,056,400 NA  NA  4.01
2007  NA  49,100 NA  NA  1,092,400 NA  13,100 4.49
2008  NA  41,800 NA  NA  1,128,350 NA   5,850 3.70
"Upper Bound" 
2006  NA  NA  54,700 NA  NA  1,156,400 NA  4.73
2007  NA  NA  62,900 NA  NA  1,192,400 26,900 5.28
2008  NA  NA  53,800 NA  NA  1,228,350 17,850 4.38
*Note: These figures can be compared to CDC's reported (and estimated) deaths for persons living with HIV in years 2006, 2007 and 2008 which are 15,074 (16,319), 14,162 
(16,297) and 12,875 (16,769), respectively [12]. 28    The Open AIDS Journal, 2012, Volume 6  Holtgrave et al. 
  It is important to routinely update the best available 
estimates of T(x) for several reasons (even if there are clear 
methodological challenges and uncertainty in calculating 
T(x)). First, T(x) plays a key role in the National HIV/AIDS 
Strategy (NHAS) and it is critical to continually refine 
methods for estimating T(x) so that as soon as possible an 
estimate for T(2010) can be made to set a baseline for the 
NHAS [7]. Second, even if somewhat imprecise, the 
estimates of T(x) can provide some insights into how much 
progress HIV prevention efforts have made in the U.S., and 
how much work remains to be done [5, 13, 14]. For instance, 
Hall  et al. used transmission rate modeling to project the 
course of the HIV epidemic in the U.S. for the next decade 
and to assess the possible impact of various scenarios for 
scaling up HIV prevention efforts [5]. 
  Also, we can compare the U.S. transmission rate to the 
lowest regional rates from across the globe. For 2007, it has 
been estimated that the Western/Central Europe HIV 
transmission rate is approximately 3.7 (the overall global 
transmission for that year is approximately 8.2) [13]. For 
2005, it has been estimated that the HIV transmission rate 
for Thailand (a country widely acknowledged to have a 
highly successful HIV prevention program) is 2.9 [14]. 
While there are many methodological challenges in 
comparing the U.S. T(x) to those for Europe, Thailand, and 
even the entire globe, doing so does give some crude sense 
that the U.S. is closer to the lower end of the observed 
continuum than to the higher end. This would suggest that 
continued improvements in T(x) for the U.S. are very much 
needed but also could be progressively harder to achieve. 
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